HealthDay News Cannabis use disorder (CUD) is associated with an increased risk for oral cancer, according to a study published in the September issue of Preventive Medicine Reports.

The FDA is expected to decide on treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy.

CMTX-101 is an investigational immune-enabling antibody designed to target and destroy the pro-inflammatory structure of bacteria biofilms.

The randomized, double-blind, placebo-controlled MODEL trial (ClinicalTrials.gov Identifier: NCT05516992) evaluated the safety and efficacy of SB-01 in 417 adults with CLBP and related disability due ...